Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
A series of new studies has shown that Prandin (repaglinide), a new oral antidiabetic drug, is effective in providing 24-hour control of blood glucose levels in people with type 2 diabetes. Prandin stimulates beta cells within the pancreas to produce insulin and is taken just before each meal, when insulin is needed. The drug reduces risk of hyperinsulinemia (excess insulin) or severe hypoglycemia (low glucose levels) by allowing insulin levels to return toward baseline between meals and at night.
Prandin was approved by the Food and Drug Administration in December 1997 and is marketed by Novo Nordisk.
Aug 1, 1998